Homeoprotein Six2 promotes breast cancer metastasis via transcriptional and epigenetic control of E-cadherin expression.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Cancer Research

• Publication date

  2014-12-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/0008-5472.CAN-14-0666PMID 25348955PMCID PMC4268359
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• ZEB/miR‐200 feedback loop: At the crossroads of signal transduction in cancer

  2013influential reference
• Epithelial-mesenchymal transition and tumor suppression are controlled by a reciprocal feedback loop between ZEB1 and Grainyhead-like-2.

  2013cited by this paper
• The pluripotent renal stem cell regulator SIX2 is activated in renal neoplasms and influences cellular proliferation and migration.

  2013cited by this paper
• 5-aza-2′-Deoxycytidine Enhances the Radiosensitivity of Breast Cancer Cells

  2013cited by this paper
• SIX2 and CITED1, markers of nephronic progenitor self-renewal, remain active in primitive elements of Wilms' tumor.

  2012cited by this paper
• SIX1 promotes epithelial–mesenchymal transition in colorectal cancer through ZEB1 activation

  2012cited by this paper
• E-cadherin promotor methylation and mutation are inversely related to motility capacity of breast cancer cells

  2012cited by this paper
• EMT-activating transcription factors in cancer: beyond EMT and tumor invasiveness

  2012cited by this paper
• MicroRNA-10b targets E-cadherin and modulates breast cancer metastasis

  2012cited by this paper
• Expression of Six1 in luminal breast cancers predicts poor prognosis and promotes increases in tumor initiating cells by activation of extracellular signal-regulated kinase and transforming growth factor-beta signaling pathways

  2012cited by this paper
• SIX1 induces lymphangiogenesis and metastasis via upregulation of VEGF-C in mouse models of breast cancer.

  2012influential reference
• Down-regulation of epithelial cadherin is required to initiate metastatic outgrowth of breast cancer

  2011cited by this paper
• Expanding roles of ZEB factors in tumorigenesis and tumor progression.

  2011cited by this paper
• GOBO: Gene Expression-Based Outcome for Breast Cancer Online

  2011cited by this paper
• A genomic predictor of response and survival following taxane-anthracycline chemotherapy for invasive breast cancer.

  2011cited by this paper
• Demethylating agent 5-aza-2-deoxycytidine enhances susceptibility of breast cancer cells to anticancer agents

  2010cited by this paper
• miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis

  2010cited by this paper
• E‐cadherin transcriptional down‐regulation by epigenetic and microRNA‐200 family alterations is related to mesenchymal and drug‐resistant phenotypes in human breast cancer cells

  2010cited by this paper
• The role of the ZEB family of transcription factors in development and disease

  2009cited by this paper
• Metastasis: from dissemination to organ-specific colonization

  2009cited by this paper
• The Six1 homeoprotein induces human mammary carcinoma cells to undergo epithelial-mesenchymal transition and metastasis in mice through increasing TGF-beta signaling.

  2009cited by this paper
• Anchorage-independent cell growth signature identifies tumors with metastatic potential

  2009cited by this paper
• Predicting protein-protein interactions in Arabidopsis thaliana through integration of orthology, gene ontology and co-expression

  2009cited by this paper
• Six2 defines and regulates a multipotent self-renewing nephron progenitor population throughout mammalian kidney development.

  2008cited by this paper
• The six family of homeobox genes in development and cancer.

  2008cited by this paper
• Repression of E-cadherin by the polycomb group protein EZH2 in cancer

  2008cited by this paper
• Transcriptional regulation by C-terminal binding proteins.

  2007cited by this paper
• Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesis.

  2006cited by this paper
• Genetic reclassification of histologic grade delineates new clinical subtypes of breast cancer.

  2006cited by this paper
• Six2 is required for suppression of nephrogenesis and progenitor renewal in the developing kidney

  2006influential reference
• Epigenetic therapy of cancer: past, present and future

  2006cited by this paper
• The transcription factor Six2 activates expression of the Gdnf gene as well as its own promoter.

  2004cited by this paper
• The Six1 homeoprotein stimulates tumorigenesis by reactivation of cyclin A1.

  2004cited by this paper
• A multigenic program mediating breast cancer metastasis to bone.

  2003cited by this paper
• E‐cadherin—catenin cell—cell adhesion complex and human cancer

  2000cited by this paper
• E-cadherin Mediates Aggregation-dependent Survival of Prostate and Mammary Epithelial Cells through the Retinoblastoma Cell Cycle Control Pathway*

  1999cited by this paper
• Cell-Cell Dissociation upon Epithelial Cell Scattering Requires a Step Mediated by the Proteasome*

  1999cited by this paper
• E-Cadherin–dependent Growth Suppression is Mediated by the Cyclin-dependent Kinase Inhibitor p27KIP1

  1998cited by this paper
• A causal role for E-cadherin in the transition from adenoma to carcinoma

  1998cited by this paper
• Reduced E-cadherin expression is associated with invasiveness and unfavorable prognosis in breast cancer.

  1996cited by this paper
• E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas.

  1995cited by this paper
• Decreased E-cadherin expression is associated with poor prognosis in patients with prostate cancer.

  1994cited by this paper
• Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor.

  1992cited by this paper
• Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role.

  1991cited by this paper

• Retinal determination network reactivation drives chemoresistance and blocks myeloid differentiation in acute myeloid leukemia.

  2026cites this paper
• TRIM21-mediated ubiquitination of SIX2 attenuates breast cancer stemness via LGSN suppression

  2025influential citation
• Cryo-EM structures reveal the PP2A–B55α and Eya3 interaction that can be disrupted by a peptide inhibitor

  2025cites this paper
• Single cell transcriptomics in a treatment-segregated cohort exposes a STAT3-regulated therapeutic gap in idiopathic pulmonary fibrosis

  2025cites this paper
• The Role of the SIX Family in Cancer Development and Therapy: Insights from Foundational and Cutting-Edge Research.

  2025cites this paper
• Heparan sulfate N-deacetylase/N-sulfotransferase-1 regulates glioblastoma cell migration and invasion.

  2025cites this paper
• SIX2 promotes cell plasticity via Wnt/β-catenin signalling in androgen receptor independent prostate cancer

  2024cites this paper
• Differential somatic coding variant landscapes between laser microdissected luminal epithelial cells from canine mammary invasive ductal solid carcinoma and comedocarcinoma

  2024cites this paper
• Integrated analysis reveals a novel 5-fluorouracil resistance-based prognostic signature with promising implications for predicting the efficacy of chemotherapy and immunotherapy in patients with colorectal cancer

  2024cites this paper
• All eyes on Eya: A unique transcriptional co-activator and phosphatase in cancer.

  2024cites this paper
• A Benzarone Derivative Inhibits EYA to Suppress Tumor Growth in SHH Medulloblastoma.

  2024cites this paper
• Dephosphorylation of Six2Y129 protects tyrosine hydroxylase-positive cells in SNpc by regulating TEA domain 1 expression

  2023cites this paper
• Knockdown of SIX4 inhibits pancreatic cancer cells via apoptosis induction

  2023cites this paper
• Non-coding RNAs: a promising target for early metastasis intervention

  2023cites this paper
• The value of EYA1/3/4 in clear cell renal cell carcinoma: a study from multiple databases

  2023cites this paper
• Evolutionary route of nasopharyngeal carcinoma metastasis and its clinical significance

  2023cites this paper
• High-Intensity Aerobic Exercise Suppresses Cancer Growth by Regulating Skeletal Muscle-Derived Oncogenes and Tumor Suppressors

  2022cites this paper
• Clinical utility of PDX cohorts to reveal biomarkers of intrinsic resistance and clonal architecture changes underlying acquired resistance to cetuximab in HNSCC

  2022cites this paper
• Krüppel-like factor 9 upregulates E-cadherin transcription and represses breast cancer invasion and metastasis.

  2021cites this paper
• DDX3X: structure, physiologic functions and cancer

  2021cites this paper
• The SIX Family of Transcription Factors: Common Themes Integrating Developmental and Cancer Biology

  2021cites this paper
• Development and Validation of a Novel 13-Genes Prognostic Model for Colon Cancer

  2021cites this paper
• Smarcd1 antagonizes the apoptosis of injured MES23.5 DA cells by enhancing the effect of Six2 on GDNF expression.

  2021cites this paper
• Dysregulation of cancer genes by recurrent intergenic fusions

  2020influential citation
• Circular RNA 0007255 regulates the progression of breast cancer through miR‐335‐5p/SIX2 axis

  2020cites this paper
• A transcriptional regulatory atlas of coronavirus infection of human cells

  2020cites this paper
• Consensus transcriptional regulatory networks of coronavirus-infected human cells

  2020cites this paper
• Epithelial–mesenchymal plasticity: emerging parallels between tissue morphogenesis and cancer metastasis

  2020cites this paper
• miR‐802 inhibits the proliferation, invasion, and epithelial‐mesenchymal transition of glioblastoma multiforme cells by directly targeting SIX4

  2019cites this paper
• Transcriptional factor six2 promotes the competitive endogenous RNA network between CYP4Z1 and pseudogene CYP4Z2P responsible for maintaining the stemness of breast cancer cells

  2019cites this paper
• Utilization of NGS technologies to investigate transcriptomic and epigenomic mechanisms in trastuzumab resistance

  2019cites this paper
• Six2 promotes non–small cell lung cancer cell stemness via transcriptionally and epigenetically regulating E‐cadherin

  2019cites this paper
• Tumor-suppressive activity of Hnf1β in Wilms’ tumor

  2019influential citation
• PPARG Negatively Modulates Six2 in Tumor Formation of Clear Cell Renal Cell Carcinoma

  2019cites this paper
• SIX4 activates Akt and promotes tumor angiogenesis.

  2019cites this paper
• Epigenetic changes in fibroblasts drive cancer metabolism and differentiation

  2019cites this paper
• SIX2 Mediates Late-Stage Metastasis via Direct Regulation of SOX2 and Induction of a Cancer Stem Cell Program.

  2019cites this paper
• The Eya phosphatase: Its unique role in cancer.

  2018cites this paper
• SIRT3 inhibits prostate cancer metastasis through regulation of FOXO3A by suppressing Wnt/&bgr;‐catenin pathway

  2018cites this paper
• The Cdc 42 / Rac 1 regulator CdGAP is a novel E-cadherin transcriptional co-repressor with Zeb 2 in breast cancer

  2018influential citation
• Role of Hoxa2 and its Putative Downstream Target Htra1 in Osteogenic Differentiation of the Palatal Mesenchyme

  2018cites this paper
• Six2 is negatively correlated with good prognosis and decreases 5-FU sensitivity via suppressing E-cadherin expression in hepatocellular carcinoma cells.

  2018cites this paper
• MicroRNA-675-3p promotes esophageal squamous cell cancer cell migration and invasion

  2018cites this paper
• SIX4 promotes metastasis via activation of the PI3K-AKT pathway in colorectal cancer

  2017cites this paper
• Six2 Plays an Intrinsic Role in Regulating Proliferation of Mesenchymal Cells in the Developing Palate

  2017cites this paper
• The YAP1/SIX2 axis is required for DDX3-mediated tumor aggressiveness and cetuximab resistance in KRAS-wild-type colorectal cancer

  2017cites this paper
• Six2 is involved in GATA1-mediated cell apoptosis in mouse embryonic kidney-derived cell lines

  2017cites this paper
• For robust big data analyses: a collection of 150 important pro-metastatic genes

  2017cites this paper
• The Cdc42/Rac1 regulator CdGAP is a novel E-cadherin transcriptional co-repressor with Zeb2 in breast cancer

  2016cites this paper
• MicroRNA-185 inhibits cell proliferation and epithelial-mesenchymal transition in hepatocellular carcinoma by targeting Six2.

  2016cites this paper
• Cadherins: The Superfamily Critically Involved in Breast Cancer.

  2016cites this paper
• Transcription factor Six2 mediates the protection of GDNF on 6-OHDA lesioned dopaminergic neurons by regulating Smurf1 expression

  2016cites this paper
• The expression profile and clinic significance of the SIX family in non-small cell lung cancer

  2016cites this paper
• Expression profile of SIX family members correlates with clinic-pathological features and prognosis of breast cancer

  2016cites this paper
• Loss of Zeb2 in mesenchyme-derived nephrons causes primary glomerulocystic disease.

  2016cites this paper
• p53 controls colorectal cancer cell invasion by inhibiting the NF-κB-mediated activation of Fascin

  2015cites this paper
• Pygopus-2 promotes invasion and metastasis of hepatic carcinoma cell by decreasing E-cadherin expression

  2015cites this paper
• Six2 exhibits a temporal-spatial expression profile in the developing mouse palate and impacts cell proliferation during murine palatogenesis

  2015cites this paper